A photo of Halley Wasserman.

Member, Division of Endocrinology

Assistant Professor, UC Department of Pediatrics

513-636-4744

Board Certified

"it is important to have joint decision-making between the medical team and the families and caregivers to determine the best approach for the individual patient."

My Biography & Research

Biography

As a pediatric endocrinologist, my clinical care and research focus on disorders of bone mineralization, pediatric osteoporosis and puberty disorders. I was drawn to this field because I wanted to help children and their families manage these conditions and live a full life.

Pediatric bone health is influenced by many factors, making each patient's story unique. Treatments for pediatric bone disorders are not always straightforward or clear cut. That’s why it is important to have joint decision-making between the medical team and the families and caregivers to determine the best approach for the individual patient.

Our team strives to educate families on their child's condition so that they can make good decisions about their care. We also are accessible for families as questions come up along the way.

I was honored to be one of Cincinnati Magazine’s Top Doctors in 2020. I also serve on committees within the Pediatric Endocrine Society and the International Society for Clinical Densitometry to develop guidelines and educate clinicians about pediatric bone disorders.

My research aims to understand the modifiable risk factors for fragility fractures in pediatric patients. My colleagues and I are also testing interventions to optimize bone health during childhood.

In my spare time, I absolutely love going to the Cincinnati Zoo. I would go there every week if I could.

Clinical Interests

Pediatric endocrinology; calcium and phosphorus mineralization disorders; osteoporosis; pubertal disorders; skeletal growth

Research Interests

Osteoporosis specifically in populations with limited mobility; puberty and reproductive health

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Clinical Divisions

Endocrinology

Research Divisions

Endocrinology

My Locations

My Education

MD: Northeastern Ohio Medical University, Rootstown, OH, 2009.

Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2012.

Endocrine Fellowship: Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2015.

Research Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2016.

MS: Clinical and Translational Research, University of Cincinnati, Cincinnati, OH, 2016.

Certification: Pediatrics, 2012; Pediatric Endocrinology, 2015.

My Publications

Selected Publication

The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position. Weber, DR; Boyce, A; Gordon, C; Hoglee, W; Kecskemethy, HH; Misra, M; Swolin-Eide, D; Tebben, P; Ware, LM; Wasserman, H; et al. Journal of Clinical Densitometry. 2019; 22:567-589.

Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review. Nasomyont, N; Hornung, LN; Gordon, CM; Wasserman, H. Bone. 2019; 121:60-67.

Use of dual energy X-ray absorptiometry in pediatric patients. Wasserman, H; O'Donnell, JM; Gordon, CM. Bone. 2017; 104:84-90.

Bone Mineralization and Fracture Risk Assessment in the Pediatric Population. Wasserman, H; Gordon, CM. Journal of Clinical Densitometry. 2017; 20:389-396.

Low bone mineral density and fractures are highly prevalent in pediatric patients with spinal muscular atrophy regardless of disease severity. Wasserman, HM; Hornung, LN; Stenger, PJ; Rutter, MM; Wong, BL; Rybalsky, I; Khoury, JC; Kalkwarf, HJ. Neuromuscular Disorders. 2017; 27:331-337.

Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia. Wasserman, H; Ikomi, C; Hafberg, ET; Miethke, AG; Bove, KE; Backeljauw, PF. Pediatrics. 2016; 138:e20154453-e20154453.

Intermachine differences in DXA measurements vary by skeletal site, and impact the assessment of low bone density in children. Zemel, BS; Wasserman, H; Kelly, A; Fan, B; Shepherd, J; Lappe, J; Gilsanz, V; Oberfield, S; Winer, KK; Kalkwarf, HJ. Bone. 2020; 141:115581-115581.

Bone Shock Absorption in Pediatric Patients With Osteogenesis Imperfecta – A Pilot Study to Assess the Potential of this Technique to Detect Differences in Bone Fragility. Nelson, ML; Cox, C; Altman, L; Khoury, J; Bhattacharya, A; Wasserman, H. Journal of Clinical Densitometry. 2020; 23:685-689.

Long-Term Follow-up of Hypophosphatemic Bone Disease Associated With Elemental Formula Use: Sustained Correction of Bone Disease After Formula Change or Phosphate Supplementation. Eswarakumar, AS; Ma, NS; Ward, LM; Backeljauw, P; Wasserman, H; Weber, DR; DiMeglio, LA; Imel, EA; Gagne, J; Cody, D; et al. Clinical Pediatrics. 2020; 59:1080-1085.

Intravenous bisphosphonate therapy in children with spinal muscular atrophy. Nasomyont, N; Hornung, LN; Wasserman, H. Osteoporosis International. 2020; 31:995-1000.